Development and Validation of the German Version of the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)
- PMID: 40805835
- PMCID: PMC12346398
- DOI: 10.3390/healthcare13151802
Development and Validation of the German Version of the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm)
Abstract
Background: As a disease with a still largely unknown course, post-COVID requires a comprehensive multidimensional perspective and structured monitoring, as offered by the C19-YRSm. There has not yet been a German version of the scale. Methods: After the translation of the COVID-19 Yorkshire Rehabilitation Scale (modified version, C19-YRSm) into German, we conducted an online survey with it between 23 May 2023 and 10 May 2024 for patients with post-COVID condition. Participation took place twice; people received either only the German version or both the German and the original English versions of the scale at one-week intervals. Based on the results, reliability and validity of the German version of the C19-YRSm were extensively tested. Results: Data of 414 participants were analysed, 156 of whom took part twice at least seven days apart. Cronbach's alpha coefficients of the subscales of the German version ranged from 0.75 to 0.93. In the English version, it ranged from 0.82 to 0.93. All the subscales correlate with each other with p < 0.001. For the overall scale and for three of the four subscales, the intraclass coefficients, as a measure of the agreement between measurement results at two points in time, showed good consistency. Conclusions: This study confirmed the reliability, applicability, and clinical utility of the C19-YRSm, aligning with previous studies. With its multidimensional structure and excellent quality criteria, the C19-YRS is a valuable asset for clinical practice and research. The validated German C19-YRSm holds significant potential to facilitate tailored interventions, destigmatise post-COVID conditions, and enhance patient care in medical contexts.
Keywords: C19-YRS(m); C19-Yorkshire Rehabilitation Scale (modified); long COVID; monitoring long COVID; post-COVID condition; translation.
Conflict of interest statement
The authors declare no conflicts of interest. The funder had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780. Cochrane Database Syst Rev. 2024. PMID: 39679851 Free PMC article.
-
Reminiscence therapy for dementia.Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3. Cochrane Database Syst Rev. 2018. PMID: 29493789 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
References
-
- World Health Organization WHO Coronavirus (COVID-19) Dashboard. 2023. [(accessed on 13 May 2025)]. Available online: https://data.who.int/dashboards/covid19/cases.
-
- Gutzeit J., Weiß M., Nürnberger C., Lemhöfer C., Appel K.S., Pracht E., Reese J.-P., Lehmann C., Polidori M.C., Hein G. Definitions and symptoms of the post-COVID syndrome: An updated systematic umbrella review. Eur. Arch. Psychiatry Clin. Neurosci. 2025;275:129–140. doi: 10.1007/s00406-024-01868-y. - DOI - PMC - PubMed
-
- Fernandez-de-Las-Peñas C., Notarte K.I., Macasaet R., Velasco J.V., Catahay J.A., Ver A.T., Chung W., Valera-Calero J.A., Navarro-Santana M. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J. Infect. 2024;88:77–88. doi: 10.1016/j.jinf.2023.12.004. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials